Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB26FSLD8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,838
Award facts
- Contract value 100% obligated
- $6,837.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,837.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pen injectors. This competitively awarded, firm fixed-price contract was executed on November 6, 2025, with an ultimate completion date of November 7, 2025, and does not include a set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other allergic inflammatory conditions, representing a critical specialty pharmaceutical commodity for military healthcare programs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen maintains responsibility for supplying an extensive range of brand-name and generic medications, specialty drugs, vaccines, and related medical supplies to support the Defense Health Agency and other federal military healthcare systems. The company's extensive contract portfolio demonstrates its capacity to fulfill federal procurement requirements across diverse therapeutic domains through competitive delivery orders with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DB26FSLD8?
SPE2DB26FSLD8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FSLD8 worth?
The government has obligated $6,838 on SPE2DB26FSLD8.
Is contract SPE2DB26FSLD8 an order under another contract?
Yes. SPE2DB26FSLD8 is a delivery order under SPE2DB20D7061, an indefinite delivery contract.
Was contract SPE2DB26FSLD8 competed?
The extent of competition for SPE2DB26FSLD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award